Prothena Corp Appoints New Director, Reports Executive Compensation
Ticker: PRTA · Form: 8-K · Filed: Dec 30, 2024 · CIK: 1559053
| Field | Detail |
|---|---|
| Company | Prothena Corp Public Ltd Co (PRTA) |
| Form Type | 8-K |
| Filed Date | Dec 30, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: board-of-directors, executive-compensation, governance
TL;DR
Prothena adds a new director, Weiler, and filed exec comp details. Board changes are always worth watching.
AI Summary
On December 29, 2024, Prothena Corporation plc announced changes to its Board of Directors. Dr. Tracey L. Weiler has been appointed as a new director, effective immediately. Additionally, the company reported on compensatory arrangements for its named executive officers, though specific details of these arrangements were not provided in this filing.
Why It Matters
Changes in board composition can signal shifts in company strategy or governance, while executive compensation details are crucial for understanding how leadership is incentivized.
Risk Assessment
Risk Level: low — This filing primarily concerns board appointments and compensatory arrangements, which are routine disclosures and do not indicate immediate financial distress or significant operational changes.
Key Players & Entities
- Prothena Corporation plc (company) — Registrant
- Dr. Tracey L. Weiler (person) — Newly appointed director
FAQ
Who is Dr. Tracey L. Weiler and what is her background?
The filing does not provide specific details about Dr. Tracey L. Weiler's background or qualifications beyond her appointment as a director.
When was Dr. Tracey L. Weiler's appointment effective?
Dr. Tracey L. Weiler's appointment as a director was effective immediately as of December 29, 2024.
What specific compensatory arrangements were disclosed for the named executive officers?
The filing states that compensatory arrangements of certain officers were reported, but the specific details of these arrangements are not provided within this document.
Are there any other changes to the Board of Directors mentioned in this filing?
This filing specifically mentions the appointment of Dr. Tracey L. Weiler as a new director; no other board changes are detailed.
What is the significance of reporting on compensatory arrangements?
Reporting on compensatory arrangements is a requirement to inform shareholders about how executive compensation is structured and to ensure transparency in executive pay.
Filing Stats: 489 words · 2 min read · ~2 pages · Grade level 13.2 · Accepted 2024-12-30 16:07:58
Key Financial Figures
- $0.01 — Registered Ordinary Shares, par value $0.01 per share PRTA The Nasdaq Global Se
Filing Documents
- d917788d8k.htm (8-K) — 22KB
- 0001193125-24-286866.txt ( ) — 144KB
- prta-20241229.xsd (EX-101.SCH) — 3KB
- prta-20241229_lab.xml (EX-101.LAB) — 18KB
- prta-20241229_pre.xml (EX-101.PRE) — 11KB
- d917788d8k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date:December 30, 2024 PROTHENA CORPORATION PLC By: /s/ Tran B. Nguyen Name: Tran B. Nguyen Title: Chief Strategy Officer and Chief Financial Officer